Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index rising 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.8%.
The iShares Biotechnology ETF (IBB) advanced 1.2%.
In corporate news, Kymera Therapeutics (KYMR) shares jumped 14% after the company said it has completed enrollment in its phase 2b Broaden2 trial of KT-621 in moderate to severe atopic dermatitis ahead of schedule.